2C-B 433
the drug along with monoamine oxidase inhibitors (MAOIs), found in some
antidepressants, lest the combination make a 2C-B dose too strong.
Abuse factors.Not enough scientific information to report.
Drug interactions.Not enough scientific information to report.
Cancer.Not enough scientific information to report.
Pregnancy.Not enough scientific information to report.
Additional scientific information may be found in:
De Boer, D., et al. “More Data about the New Psychoactive Drug 2C-B.”Journal of
Analytical Toxicology23 (1999): 227–28.
Giroud, C., et al. “2C-B: A New Psychoactive Phenylethylamine Recently Discovered
in Ecstasy Tablets Sold on the Swiss Black Market.”Journal of Analytical Toxi-
cology22 (1998): 345–54.
“Schedules of Controlled Substances; Placement of 4-Bromo-2,5-Dimethoxyphenethy-
lamine into Schedule I.”Federal Register55 (1996): 28718–719.
Who Expert Committee on Drug Dependence. “Thirty-Second Report.”WHO Technical
Report Series903 (2001): 6–8.